Article Information
History
- March 31, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jose Lenin Beltran Gonzalez, MD1,*,
- Mario González Gámez, MD1,
- Emmanuel Antonio Mendoza Enciso, MD1,
- Ramiro Josue Esparza Maldonado, MD1,
- Daniel Hernández Palacios, MD1,
- Samuel Dueñas Campos, MD1,
- Itzel Ovalle Robles, MD1,
- Mariana Jocelyn Macías Guzmán, MD1,
- Andrea Lucia García Díaz, MD1,
- César Mauricio Gutiérrez Peña, MD1,
- Ana Lilian Reza-Escalera, MD1,
- Maria Teresa Tiscareño Gutierrez, MD1,
- Elva Galvan-Guerra, QFB2,
- Maria del Rocio Dorantes Morales, MD3,
- Lucila Martínez Medina, MD MSc.4,
- Victor Antonio Monroy Colin, MD4 and
- Arreola Guerra Jose Manuel, MD MSc, PhD1,*
- 1Internal Medicine Department Centenario Hospital Miguel Hidalgo
- 2Laboratorio Clinico del Campestre
- 3Aguascalientes State Transfusion Center
- 4Pediatrics Department Centenario Hospital Miguel Hidalgo
- ↵*Corresponding Authors:
José Manuel Arreola Guerra, MD, M. Sc., Ph.D, Head, Department of Investigation, Nephrologist, and Associate Professor of Internal Medicine., Hospital Centenario Miguel Hidalgo, Av Gómez Morín y Av La Estación, La Alameda, Aguascalientes, Aguascalientes Mexico., C.P. 20259, Tel.: 521 4499946720,dr.jmag{at}gmail.com, Mario Gonzalez Gamez MD, Department of Internal Medicine and Infectologist, Hospital Centenario Miguel Hidalgo, Av Gómez Morín y Av La Estación, La Alameda, Aguascalientes, Aguascalientes Mexico., C.P. 20259, Tel.: 521 4499946720,mariogzg{at}hotmail.com
Posted March 31, 2021.
Efficacy and safety of convalescent plasma and intravenous immunoglobulin in critically ill COVID-19 patients. A controlled clinical trial
